Zelig Eshhar, a cancer researcher and immunologist, has died at 84. He is credited with engineering immune cells to fight cancer, a breakthrough that may also have implications for treating other diseases, including Alzheimer's. The impact of his work is reflected in the development of CAR T-cell therapy, a field that has led to the establishment of numerous companies and has been recognized with prestigious awards.